One of social media’s most popular platforms, Twitter, is altering their advertising policies on cannabis.
Twitter is loosening its reins on cannabis industry advertising. Vetted, state-legal businesses will now be able to show packaged cannabis products in their marketing campaigns while also allowing ads in new US markets (1).
Alexa Alianiello, Twitter’s head of sales and partnerships, wrote in a blog post (2) that certified cannabis advertisers “may also continue responsibly linking to their owned and operated web pages and e-commerce experiences for cannabidiol (CBD), tetrahydrocannabinol (THC), and cannabis-related products and services.” Alianiello added, “We have also made some changes for medical licensees and opened up additional recreational markets (some restrictions apply).”
On Twitter’s drug advertising policy (3), it does not specify which new recreational and medical markets are now available for cannabis advertising.
The social media platform will now permit medical cannabis ads targeting users in Alabama, Arkansas, Florida, Minnesota, Mississippi, Missouri, Oklahoma, Pennsylvania, Puerto Rico, Rhode Island, South Dakota and West Virginia, according to information provided by Rosie Mattio, founder and CEO of New York-based cannabis industry marketing firm Mattio Communications (1). The state of Missouri will also be permitted to utilize adult-use cannabis ads in their newly-formed adult-use market.
Mattio reported to MJBizDaily (1) that Twitter’s decision to allow images of packaged cannabis products brings “a lot more opportunity for these brands to reach consumers and teach them about the actual product, (as opposed to) it just being a brand-awareness type of play.”
Elon Musk’s Twitter turned a new leaf in February 2023, allowing cannabis ads onto their platform (4). This move was very much welcomed and appreciated by cannabis industry marketing leaders. However, cannabis companies witnessed mixed results in their marketing on the privately held social media platform.
“We have seen companies of all sizes try to advertise on Twitter,” said Lisa Buffo, founder and CEO of the Cannabis Marketing Association (1). “Some, not all, have been approved, and others have had early and mixed results,” she continued. “With any advertising initiative, success depends on the match of the brand and the campaign to the platform – it’s not a one-size-fits-all approach.”
Alianiello mentioned in her Twitter blog post (2), announcing the ad-policy updates, commenting on how the platform has “gathered meaningful feedback from the cannabis industry which we have taken into consideration to create even more opportunity.”
“It appears that they are iterating and taking feedback from the industry and better understanding the nuances of local laws and regulations,” said Buffo chimed in (1). “That should signal to the broader advertising world that a national approach to cannabis marketing is possible, when taken in small and iterative steps.”
Other social media platform giants such as Facebook and Instagram parent company Meta and Google parent company Alphabet, usually do not allow cannabis marketing but Google has made exceptions for certain CBD and hemp ads.
The US is not the only country Twitter allows cannabis advertising. Canada and Thailand are also contingent to the social platforms’ policies.
References
Ep 25: Cannabis Quality Differentiation Beyond Cannabinoid Content
February 28th 2025In this latest installment of Noid Knowledge we are joined by Julie Kowalski, a leading mind in analytical chemistry and cannabis testing. Julie has arranged a very compelling symposium for Pittcon entitled Cannabis Aroma: Advances and Challenges in Determining and Commercializing Cannabis Product Quality Attributes. It is taking place on Wednesday, March 5, 2025, starting at 9:30 AM in room 209. The session features top notch speakers, including several previous guests of this show, and yours truly, discussing the next generation of quality assessment in cannabis.
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.